triethylenemelamine has been researched along with Acquired Autoimmune Hemolytic Anemia in 5 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TAYLOR, L | 1 |
| MOLANDER, DW | 1 |
| LADUE, JS | 1 |
| Silver, RT | 1 |
| Weinreich, J | 1 |
| Lewis, FB | 1 |
| Schwartz, RS | 1 |
| Dameshek, W | 1 |
1 review available for triethylenemelamine and Acquired Autoimmune Hemolytic Anemia
| Article | Year |
|---|---|
The treatment of chronic lymphocytic leukemia.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Ag | 1969 |
4 other studies available for triethylenemelamine and Acquired Autoimmune Hemolytic Anemia
| Article | Year |
|---|---|
IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA. RESPONSE OF A PATIENT TO REPEATED COURSES OF ALKYLATING AGENTS.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune | 1963 |
CHRONIC LEUKEMIA.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alkylating Agents; Anemia; Anemia, Hemolytic, | 1964 |
[Autoimmune hemolytic anemia and as a result of x-ray and cytostatic treatment in lymphatic leukemia].
Topics: Anemia, Hemolytic, Autoimmune; Humans; Immune Tolerance; Leukemia, Lymphoid; Male; Middle Aged; Radi | 1967 |
X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Chlorambucil; Humans; Leukemia, Lymphoid; Lymphoma, Non- | 1966 |